CellDetect® Innovative Staining Platform – The Power of Color for Early Cancer Detection

Please log in for more information

Zetiq, a fully-owned subsidiary of Micromedic Technologies, presents CellDetect^®, an innovative staining platform using both color and morphology to discriminate between normal and neoplastic cells.

Applicable to a variety of specimens including histological tissues and cytological smears, CellDetect^® highlights suspicious cells in red-purple, therefore enhancing accuracy and increasing throughput.

CellDetect^® Bladder cancer kit for the monitoring of bladder cancer recurrence in urine specimens provides high sensitivity, particularly for the detection of low grade tumors. Suitable for both liquid-based and conventional cytology, the technology uses standard lab staining processes and is potentially applicable for digital cytopathology.

CellDetect^® is a Trademark of Zetiq Technologies, a fully-owned subsidiary of Micromedic. Micromedic Technologies Ltd. (TASE: MCTC) is engaged in the development and commercialization of unique solutions addressing substantial unmet needs in the field of cancer diagnostics, primarily early cancer detection. Micromedic has initiated the process of engaging partners for the commercialization of the CellDetect^® Bladder kit in Europe and countries adopting the CE regulatory standard.

Visit website

Contact Information:

Micromedic Technologies Ltd.
Kyriat Atidim, Building 3
Tel Aviv 6158101, Israel
Phone: +972-73-2753450
Fax: +972-73-2753451
Email: info@m-medic.com

Visit website